Erin Colgan - 15 Feb 2023 Form 4 Insider Report for Sensei Biotherapeutics, Inc. (SNSE)

Role
Chief Financial Officer
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Issuer symbol
SNSE
Transactions as of
15 Feb 2023
Net transactions value
-$16,414
Form type
4
Filing time
11 Sep 2023, 17:31:54 UTC
Previous filing
17 Feb 2022
Next filing
16 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNSE Common Stock Tax liability $16,414 -10,943 -14% $1.50 68,089 15 Feb 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units.